Biggest changeYears Ended Increase / Increase / December 31, Decrease Decrease (In Thousands of USD) 2023 2022 ($) (%) Net revenues 27,120 44,757 (17,637 ) (39 ) Cost of revenues 25,688 40,405 (14,717 ) (36 ) Gross profit 1,432 4,352 (2,920 ) (67 ) Operating expenses: Selling and marketing expenses 898 2,167 (1,269 ) (59 ) General and administrative expenses 9,036 7,056 1,980 28 Research & Developing expenses 269 403 (134 ) (33 ) Operating loss (8,771 ) (5,273 ) (3,498 ) 66 Interest expense (496 ) (624 ) 128 (21 ) Other income (expense) (123 ) 1,099 (1,222 ) (111 ) Impairment of goodwill - (10,386 ) 10,386 (100 ) Share of losses from equity method investments (569 ) (84 ) (485 ) 577 Loss on disposal of equity investments (10,849 ) - (10,849 ) N/A Loss before tax (20,808 ) (15,268 ) (5,540 ) 36 Income tax expense (35 ) (1,475 ) 1,440 (98 ) Loss from continuing operations (20,843 ) (16,743 ) (4,100 ) 24 Net loss from discontinuing operations - (9,192 ) 9,192 (100 ) Net (loss) income (20,843 ) (25,935 ) 5,092 (20 ) 22 Net Revenues .
Biggest changeYears Ended Increase / Increase / December 31, Decrease Decrease (In Thousands of USD) 2024 2023 ($) (%) Net revenues 6,730 17,660 (10,930 ) (62 ) Cost of revenues 5,968 16,076 (10,108 ) (63 ) Gross profit 762 1,584 (822 ) (52 ) Operating expenses: Selling and marketing expenses 41 95 (54 ) (57 ) General and administrative expenses 7,328 7,997 (669 ) (8 ) Research & Developing expenses 57 55 2 4 Operating loss (6,664 ) (6,563 ) (101 ) 2 Interest expense (70 ) (10 ) (60 ) 600 Other income (expense) (724 ) (194 ) (530 ) 273 Share of losses from equity method investments - (569 ) 569 (100 ) Loss on disposal of equity investments - (10,849 ) 10,849 (100 ) Loss before tax (7,458 ) (18,185 ) 10,727 (59 ) Income tax expense - (35 ) 35 (100 ) Loss from continuing operations (7,458 ) (18,220 ) 10,762 (59 ) Net income (loss) from discontinuing operations 128 (2,624 ) 2,752 (105 ) Net loss (7,330 ) (20,844 ) 13,514 (65 ) Net Revenues .
As of December 31, 2023, there were no other recently issued accounting standards not yet adopted that would or could have a material effect on the Company’s consolidated financial statements. Off-Balance Sheet Arrangements We do not have any off-balance arrangements. ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK Not applicable.
As of December 31, 2024, there were no other recently issued accounting standards not yet adopted that would or could have a material effect on the Company’s consolidated financial statements. Off-Balance Sheet Arrangements We do not have any off-balance arrangements. 21 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK Not applicable.
Results of Operations The following discussion should be read in conjunction with the company’s audited consolidated financial statement for the years ended December 31, 2023, and 2022 and related notes to that.
Results of Operations The following discussion should be read in conjunction with the company’s audited consolidated financial statement for the years ended December 31, 2024, and 2023 and related notes to that.
In the previous fiscal year, 50% of our total revenue was generated from the sale of a diverse range of food products to restaurants. However, this segment has been significantly impacted by the adverse effects of COVID-19, leading to a decline in sales from $23.34 million in 2022 to $14.32 million in 2023.
In the previous fiscal year, 50% of our total revenue was generated from the sale of a diverse range of food products to restaurants. However, this segment has been significantly impacted by the adverse effects of COVID-19, leading to a decline in sales from $14.32 million in 2023 to $2.04 million in 2024. Cost of Revenues .
After a series of acquisitions and dispositions in 2023 and 2022, our primary business, which is carried out by Shandong Yunchu, Jingshan Sanhe, Jilin Chuangyuan, Fast Approach Inc and Xianning Bozhuang, is: ● To sell black tea product cultivation, packaging, and sales; ● To sell high-grade synthetic fuel products; ● To sell f ormaldehyde, urea-formaldehyde glue, methylal, and clean fuel oil; ● Online advertising services and mobile game.
After a series of acquisitions and dispositions in 2024 and 2023, our primary business, which is carried out by Shandong Yunchu, Jingshan Sanhe, Xianning Bozhuang and Fast Approach Inc, is: ● To import and distributes animal proteins, mainly beef products; ● To sell high-grade synthetic fuel products; ● To sell black tea product cultivation, packaging, and sales; ● Online advertising services.
Our net revenues for the fiscal year ending on December 31, 2023 amounted to $27.12 million, reflecting a decline of approximately $17.64 million or 39% compared to the previous year’s figure of $44.76 million (ending on December 31, 2022).
Our net revenues for the fiscal year ending on December 31, 2024 amounted to $6.73 million, reflecting a decline of approximately $10.93 million or 62% compared to the previous year’s figure of $17.66 million (ending on December 31, 2023).
Cash Flows Data: For the years ended December 31 (In thousands of U.S. dollars) 2023 2022 Net cash flows used in operating activities (5,282 ) (9,012 ) Net cash flows provided by investing activities 2,670 (3,854 ) Net cash flows provided by financing activities 2,888 10,841 Operating Activities Net cash used in operating activities decreased by $3.73 million to $5.28 million during the year ended December 31, 2023 from $9.01 million during the year ended December 31, 2022.
Cash Flows Data: For the Years Ended December 31 (In thousands of U.S. dollars) 2024 2023 Net cash flows provided by (used in) operating activities 929 (5,282 ) Net cash flows (used in) provided by investing activities (5 ) 2,471 Net cash flows (used in) provided by financing activities (972 ) 2,888 Operating Activities Net cash provided by operating activities was $0.93 million during the year ended December 31, 2024, compared to $5.28 million used in operating activities during the year ended December 31, 2023.
Our gross profit declined by $2.92 million, representing a decrease of 67% to $1.43 million for the fiscal year ended December 31, 2023 compared to $4.35 million for the fiscal year ended December 31, 2022.
Our gross profit declined by $0.82 million, representing a decrease of 52% to $0.76 million for the fiscal year ended December 31, 2024 compared to $1.58 million for the fiscal year ended December 31, 2023.
This decrease was primarily due to the decrease in net loss excluding non-cash expenses, gains and losses of $1.42 million and changes in net operating assets and liabilities of $5.15 million.
This change was primarily due to the decrease in net loss excluding non-cash expenses, gains and losses of $1.41 million, changes in net operating assets and liabilities of $5.23 million, and partially offset by a decrease in net cash provided by operating activities from discontinued operations of $0.43 million.
As of December 31, 2023, the Company had an accumulated deficit of $140,724,597, a working capital deficit of $6,675,220, its net cash used in operating activities for the year ended December 31, 2023 was $ 5,282,343. These factors raise substantial doubt on the Company’s ability to continue as a going concern.
As of December 31, 2024, the Company had an accumulated deficit of $148,053,653, a working capital deficit of $6,120,752, its net cash provided by operating activities from continuing operations for the year ended December 31, 2024 was $928,644. These factors raise substantial doubt on the Company’s ability to continue as a going concern.
Investing Activities Net cash provided by investing activities for the year ended December 31, 2023 was $2.67 million, representing an increase of $6.52 million from the $3.85 million used in investing activities for the same period in 2022.
Investing Activities Net cash used in investing activities for the year ended December 31, 2024 was $5,421, compared to $2.47 million provided by investing activities for the same period in 2023.
This decline primarily stems from a reduction of $11.10 million in proceeds generated from the issuance of common stock as opposed to 2022, partially offset by an increase of $2.97 million attributed to changes involving related parties during 2023. 24 Critical Accounting Policies The preparation of financial statements in conformity with the United States generally accepted accounting principles requires our management to make assumptions, estimates, and judgments that affect the amounts reported in the financial statements, including the notes to that, and related disclosures of commitments contingencies, if any.
Critical Accounting Policies The preparation of financial statements in conformity with the United States generally accepted accounting principles requires our management to make assumptions, estimates, and judgments that affect the amounts reported in the financial statements, including the notes to that, and related disclosures of commitments contingencies, if any.
The debt to assets ratio was 54.40% and 33.16% as of December 31, 2023 and December 31, 2022, respectively. We expect to continue to finance our operations and working capital needs in 2023 from cash generated from operations and, if needed, private financings. Suppose available liquidity is insufficient to meet our operating and loan obligations as they come due.
We expect to continue to finance our operations and working capital needs in 2024 from cash generated from operations and, if needed, private financings. Suppose available liquidity is insufficient to meet our operating and loan obligations as they come due. In that case, our plans include pursuing alternative financing arrangements or reducing expenditures as necessary to meet our cash requirements.
Net Loss Our net loss decreased by $5.09 million, or 20%, to a net loss of $20.84 million for the year ended December 31, 2023 from $25.94 million in net loss for the year ended December 31, 2022.
Net Loss Our net loss decreased by $13.51 million, or 65%, to a net loss of $7.33 million for the year ended December 31, 2024 from $20.84 million in net loss for the year ended December 31, 2023. This decrease was mainly due to the decrease in loss on the disposal of certain subsidiaries.
Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern; however, the Company has incurred a net loss of $20,843,796 attributable to common shareholders for the year ended December 31, 2023.
We cannot be sure of the availability or terms of any alternative financing arrangements. 19 Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern; however, the Company has incurred a net loss from continuing operations of $7,457,193 for the year ended December 31, 2024.
Our selling and marketing expenses decreased by $1.27 million, or 59%, to $0.90 million for the year ended December 31, 2023 from $2.17 million for the year ended December 31, 2022. This decrease was mainly due to the aforementioned reasons, attributable to a decrease in sales of revenue and the disposal of certain subsidiaries in 2022. General and Administrative Expenses.
Our selling and marketing expenses decreased by $0.05 million, or 57%, to $0.04 million for the year ended December 31, 2024 from $0.09 million for the year ended December 31, 2023, mainly due to the decrease in transportation and storage cost, as well as decline in the sales staff salaries. General and Administrative Expenses.
In that case, our plans include pursuing alternative financing arrangements or reducing expenditures as necessary to meet our cash requirements. However, there is no assurance that we will raise additional capital or reduce discretionary spending to provide liquidity if needed. We cannot be sure of the availability or terms of any alternative financing arrangements.
However, there is no assurance that we will raise additional capital or reduce discretionary spending to provide liquidity if needed.
This decrease was mainly due to the aforementioned reasons, attributable to a decrease in sales of revenue and the disposal of certain subsidiaries in 2022. Liquidity and Capital Resources In assessing our liquidity, we monitor and analyze our cash-on-hand and operating and capital expenditure commitments. Our liquidity needs meet our working capital requirements, operating expenses, and capital expenditure obligations.
Liquidity and Capital Resources In assessing our liquidity, we monitor and analyze our cash-on-hand and operating and capital expenditure commitments. Our liquidity needs meet our working capital requirements, operating expenses, and capital expenditure obligations. In the reporting period in the fiscal year 2024, our primary sources of financing have been cash generated from operations and proceeds from bank loans.
Financing Activities Net cash provided by financing activities for the year ended December 31, 2023, amounted to $2.88 million, indicating a decrease of $7.95 million compared to the corresponding period in 2022.
This change is primarily due to a reduction in proceeds from disposal of equity method investments of $2.77 million compared to the year ended December 31, 2023. 20 Financing Activities The net cash used in financing activities was $0.97 million during the year ended December 31, 2024, compared to net cash provided by financing activities of $2.89 million for the same period in 2023.
The residual decrease was attributable to disposal of certain subsidiaries in late 2022. Cost of Revenues. During the year ended December 31, 2023, we experienced a decrease in cost of revenue of $14.72 million or 36%, in comparison to the year ended December 31, 2022, from approximately $40.41 million to $25.69 million.
During the year ended December 31, 2024, we experienced a decrease in cost of revenue of $10.11 million or 63%, in comparison to the year ended December 31, 2023, from approximately $16.08 million to $5.97 million. This change was mainly due to a decrease in sales of revenue, as discussed above. 18 Gross Profit .
This decline can be primarily attributed to the aforementioned factors, namely a decrease in sales revenue and the divestiture of certain subsidiaries towards the end of 2022. Additionally, another contributing factor was a slight increase in the average combined cost per unit of our products.
This decline can be primarily attributed to the decrease in sales revenue, and partially offset by a slight decrease in the average combined cost per unit of our products. The gross profit margin increased from 9.0% in 2023 to 11.3% in 2024, representing an increase of 2.3%, primarily attributed to change in product mix. Operating Expenses Selling and Marketing Expenses.